We are conducting a clinical research to explore new possible treatment
options for generalized anxiety disorder (GAD)
To pre-qualify for this study, participants must:
Be 18 to 65 years old with Generalized Anxiety Disorder (GAD)
Be currently taking paroxetine, escitalopram, duloxetine, or venlafaxine ER for at least 8 weeks
Not be currently experiencing a depressive episode
Have no lifetime history of schizophrenia, schizoaffective disorder, bipolar I or II disorder, posttraumatic stress disorder, or developmental/cognitive disorders
Additional eligibility criteria may apply. To learn more and find out if you
qualify, please contact our study team at (714) 999 6688.
